Cecilia Radu of Novo Nordisk Romania shares her tumultuous four years that have seen declining market share and have culminated in launching the company’s first new product onto the market in several years. She reveals that the perception of diabetes in Romania is skewed, as more than 50 percent of the population believes that it is a curable disease, revealing a systemic lack of education around the subject. She shares her insights on how Novo Nordisk’s call to action in Romania has triggered the first Diabetes Forum to be hosted as well as the passing of a law regulating the national diabetes prevention program.
After six years of declining market share and not providing new molecules to the market, in 2017 the organisation started to grow anew
